SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001014763-15-000024
Filing Date
2015-10-13
Accepted
2015-10-13 15:08:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 KAIROS CAPITAL SC13D 10/13/15 kairoscapital-sc13d_10132015.htm SC 13D 65763
  Complete submission text file 0001014763-15-000024.txt   67455
Mailing Address AMARILLO BIOSCIENCES INC 4134 BUSINESS PARK DRIVE AMARILLO TX 79110-4225
Business Address AMARILLO BIOSCIENCES INC 4134 BUSINESS PARK DRIVE AMARILLO TX 79110-4225 (806) 376-1741
AMARILLO BIOSCIENCES INC (Filed by) CIK: 0001014763 (see all company filings)

IRS No.: 751974352 | State of Incorp.: TX | Fiscal Year End: 0710
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address AMARILLO BIOSCIENCES INC 4134 BUSINESS PARK DRIVE AMARILLO TX 79110-4225
Business Address AMARILLO BIOSCIENCES INC 4134 BUSINESS PARK DRIVE AMARILLO TX 79110-4225 (806) 376-1741
AMARILLO BIOSCIENCES INC (Subject) CIK: 0001014763 (see all company filings)

IRS No.: 751974352 | State of Incorp.: TX | Fiscal Year End: 0710
Type: SC 13D | Act: 34 | File No.: 005-46755 | Film No.: 151155943
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1